does semaglutide have more side effects than tirzepatide less caused roughly half as many patients to stop Compare GLP-1 Options | Ozempic

Dr Carlos Aguiar, the vice-president of the European Society of Cardiology and a renowned expert in heart failure, who was not involved with the study, welcomed the findings

Ashworth, A

Purpose-built for physicians GLP-1 receptor agonists linked to lower mortality, respiratory failure in PAH Key takeaways: A link was found between GLP-1 receptor agonist use in PAH and significant decreases in mortality, respiratory failure, atrial fibrillation and ED visits

The numbers look wildly different

Many weight-loss experts now frame GLP-1 therapy similarly to chronic-disease management: your brain's appetite-regulation system has been shaped by years of overeating patterns, making it chronically dysregulated